WO2021011885A1 - Claudin18 antibodies and methods of treating cancer - Google Patents

International application published with international search report

Emerging new therapeutic antibody derivatives for cancer treatment

WO2021024020A1 - Combination therapy involving antibodies against claudin 18.2 and immune checkpoint inhibitors for treatment of cancer - Google Patents

WO2020025792A1 - Antibody constructs for cldn18.2 and cd3 - Google Patents

WO2022063272A1 - Novel anti-claudin18 antibodies - Google Patents

Cancers, Free Full-Text

WO2021088927A1 - Antibody-drug conjugates targeting claudin 18.2 - Google Patents

WO2022063272A1 - Novel anti-claudin18 antibodies - Google Patents

US20220041712A1 - Anti-claudin 18 antibodies and methods of use thereof - Google Patents

WO2021088927A1 - Antibody-drug conjugates targeting claudin 18.2 - Google Patents

WO2021088927A1 - Antibody-drug conjugates targeting claudin 18.2 - Google Patents

WO2021024020A1 - Combination therapy involving antibodies against claudin 18.2 and immune checkpoint inhibitors for treatment of cancer - Google Patents

Claudin18.2 is a novel molecular biomarker for tumor-targeted immunotherapy, Biomarker Research

WO2021024020A1 - Combination therapy involving antibodies against claudin 18.2 and immune checkpoint inhibitors for treatment of cancer - Google Patents